What the company does
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products …
What the weekly tape is saying
GRF closed the latest completed week at 9.03 EUR. The 4-week return is -0.6% and the 12-week return is 3.2%. Trend Signal is inactive, Market Dynamics is 0.00. Setup signature: Risk-first tape with a 28/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 10.01 EUR
- Vs Trend Line
- -9.7%
- Fair Value
- 10.31 EUR
- Vs Fair Value
- -12.3%
- 52W High
- 13.54 EUR
- 52W Low
- 8.43 EUR
- Drawdown
- -33.3%
- Range Position
- 11.8%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 21
- 52W Active Breadth
- 40.4%
- Sector Scope
- ES Healthcare
- Sector Rank
- 7 of 14
- Sector Percentile
- 53.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
ES Healthcare
- Tracked Peers
- 14
- 4W Rank
- 11 of 14
- Avg 1W
- -3.1%
- Avg 4W
- -0.9%
- Trend Breadth
- 42.9%
- Positive MD
- 57.1%
ES Drug Manufacturers - General
- Tracked Peers
- 1
- 4W Rank
- 1 of 1
- Avg 1W
- -0.3%
- Avg 4W
- -0.6%
- Trend Breadth
- 0.0%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.00
- 4W MD Change
- 100.3%
- Relative Strength
- -27.01
- 4W RS Change
- -15.2%
- Expectation
- Undecided
- Probability
- 52.53%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 8.5M
- 13W Average
- 12.9M
- 52W Average
- 9.0M
- Vs 13W
- 0.7x
- Vs 52W
- 0.9x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.0%
- 52W Volatility
- 3.7%
- Upside Weeks
- 26
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 2.6% / -3.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- MCE
- Country
- ES
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- EUR
- Market Cap
- 6.3B
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 9.03 EUR | -0.3% | 10.01 EUR | 10.31 EUR | 0.00 | -27.01 | 8.5M | Off |
| 5 Jun 2026 | 9.06 EUR | -2.4% | 10.06 EUR | 10.32 EUR | -0.14 | -25.67 | 10.4M | Off |
| 29 May 2026 | 9.28 EUR | -2.0% | 10.11 EUR | 10.33 EUR | -0.31 | -24.41 | 32.1M | Off |
| 22 May 2026 | 9.47 EUR | 4.1% | 10.17 EUR | 10.35 EUR | -0.68 | -21.61 | 9.2M | Off |
| 15 May 2026 | 9.09 EUR | 1.7% | 10.23 EUR | 10.36 EUR | -0.81 | -23.45 | 13.3M | Off |
| 8 May 2026 | 8.94 EUR | -0.2% | 10.32 EUR | 10.37 EUR | -0.82 | -26.09 | 11.6M | Off |
| 1 May 2026 | 8.96 EUR | 0.1% | 10.42 EUR | 10.39 EUR | -0.84 | -25.67 | 7.0M | Off |
| 24 Apr 2026 | 8.95 EUR | -7.2% | 10.54 EUR | 10.39 EUR | -0.84 | -25.64 | 12.2M | Off |
| 17 Apr 2026 | 9.65 EUR | 8.0% | 10.64 EUR | 10.39 EUR | -0.89 | -23.57 | 13.6M | Off |
| 10 Apr 2026 | 8.93 EUR | -2.9% | 10.72 EUR | 10.39 EUR | -1.04 | -28.31 | 16.0M | Off |
| 3 Apr 2026 | 9.20 EUR | 5.5% | 10.82 EUR | 10.39 EUR | -1.05 | -23.71 | 8.0M | Off |
| 27 Mar 2026 | 8.73 EUR | -0.3% | 10.93 EUR | 10.39 EUR | -0.78 | -24.67 | 14.5M | Off |
| 20 Mar 2026 | 8.76 EUR | -5.0% | 11.04 EUR | 10.39 EUR | -0.42 | -24.26 | 11.4M | Off |
| 13 Mar 2026 | 9.22 EUR | -8.4% | 11.16 EUR | 10.39 EUR | -0.05 | -22.24 | 13.6M | Off |